OrphanDrug
OrphanDrug
Pharma Knowledge Base

familial hyperaldosteronism type 3

ORPHA: 251274

Contents

  1. 1. Available Treatments
  2. 2. Clinical Presentation
  3. 3. Classification & Codes

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with familial hyperaldosteronism type 3, sourced from HPO and Orphanet clinical annotations.

HypertensionAbnormal circulating renin concentrationHypokalemiaAdrenal hyperplasiaGlucocortocoid-insensitive primary hyperaldosteronismTinnitusEpistaxisMuscle weaknessProlonged QT intervalLeft ventricular hypertrophyPolydipsiaNauseaHypercalciuriaIntracranial hemorrhageHeadacheMetabolic alkalosis

Classification & Codes

Orphanet Code

ORPHA:251274
familial hyperaldosteronism type 3
OrphanetORPHA:251274
Treatments0 drug(s)
Symptoms on record16 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO
familial hyperaldosteronism type 3 | OrphanDrug